Gene · 9356
Papers1,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of a novel hepatitis B anti-viral drug E-CFCP in renal organic acid transporters. | J Pharmacol Sci | 2022 | 36344041 | PubTator, text mining | PubMed |
| Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency. | Proc Natl Acad Sci U S A | 2022 | 36343260 | PubTator, text mining | PubMed |
| A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia. | Evid Based Complement Alternat Med | 2022 | 36337587 | PubTator, text mining | PubMed |
| Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions. | Sci Rep | 2022 | 36316339 | PubTator, text mining | PubMed |
| Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis. | Front Oncol | 2022 | 36313709 | PubTator, text mining | PubMed |
| Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future. | Front Cardiovasc Med | 2022 | 36312261 | PubTator, text mining | PubMed |
| Effectiveness and safety of statins on outcomes in patients with HIV infection: a systematic review and meta-analysis. | Sci Rep | 2022 | 36302940 | PubTator, text mining | PubMed |
| Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021. | Pharmaceutics | 2022 | 36297514 | PubTator, text mining | PubMed |
| Apical Medium Flow Influences the Morphology and Physiology of Human Proximal Tubular Cells in a Microphysiological System. | Bioengineering (Basel) | 2022 | 36290484 | PubTator, text mining | PubMed |
| The Issue of Pharmacokinetic-Driven Drug-Drug Interactions of Antibiotics: A Narrative Review. | Antibiotics (Basel) | 2022 | 36290068 | PubTator, text mining | PubMed |
| A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection. | Retrovirology | 2022 | 36273165 | PubTator, text mining | PubMed |
| Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality. | Pulm Pharmacol Ther | 2022 | 36265833 | PubTator, text mining | PubMed |
| Evaluation of Absorption and Metabolism-Based DDI Potential of Pexidartinib in Healthy Subjects. | Clin Pharmacokinet | 2022 | 36264536 | PubTator, text mining | PubMed |
| Biological Reconstruction of Localized Full-Thickness Cartilage Defects of the Knee: A Systematic Review of Level 1 Studies with a Minimum Follow-Up of 5 Years. | Cartilage | 2022 | 36250517 | PubTator, text mining | PubMed |
| [Treatment and prevention of monkeypox]. | Enferm Infecc Microbiol Clin | 2022 | 36249471 | PubTator, text mining | PubMed |
| Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV. | Front Genet | 2022 | 36246609 | PubTator, text mining | PubMed |
| Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation. | Chem Biol Interact | 2022 | 36243147 | PubTator, text mining | PubMed |
| Research Progress on the Positive and Negative Regulatory Effects of Rhein on the Kidney: A Review of Its Molecular Targets. | Molecules | 2022 | 36235108 | PubTator, text mining | PubMed |
| Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma. | Cancers (Basel) | 2022 | 36230695 | PubTator, text mining | PubMed |
| Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoids. | Nat Commun | 2022 | 36209212 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9356/papers?page=17